Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL
Crossref DOI link: https://doi.org/10.1038/bmt.2017.191
Published Online: 2017-09-11
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
El Chaer, F
Holtzman, N
Binder, E
Porter, N C
Singh, Z N
Koka, M
Rapoport, A P
Emadi, A
Text and Data Mining valid from 2017-09-11
Version of Record valid from 2017-09-11
Article History
First Online: 11 September 2017
Competing interests
: The authors declare no conflict of interest.